Why the study?
Ischemic heart disease pathophysiology is multifaceted and not always caused by atherosclerotic plaque complications, lacking a well-defined assessment that satisfies all clinical, angiographic, and autoptic findings.
Key points are not available for this paper at this time.
Design
Overview
Answers are grounded in this paper and cite their sources.
Multifaceted IHD pathophysiology may warrant microvascular assessment; leaves open targeted intervention trials.
Ischemic heart disease still represents a large burden on individuals and health care resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow-limiting obstruction in large-medium sized coronary arteries. However, clinical, angiographic and autoptic findings suggest a multifaceted pathophysiology for ischemic heart disease and just some cases are caused by severe or complicated atherosclerotic plaques. Currently there is no well-defined assessment of ischemic heart disease pathophysiology that satisfies all the observations and sometimes the underlying mechanism to everyday ischemic heart disease ward cases is misleading. In order to better examine this complicated disease and to provide future perspectives, it is important to know and analyze the pathophysiological mechanisms that underline it, because ischemic heart disease is not always determined by atherosclerotic plaque complication. Therefore, in order to have a more complete comprehension of ischemic heart disease we propose an overview of the available pathophysiological paradigms, from plaque activation to microvascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Severino et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: